C3, Mouse, pAb
Catalog #: HP8012
Quantity: 100 µg
The complement factor C3 consists of an alpha- and a beta-chain. C3 is a central factor in the complement cascade. It is central to the alternative pathway that leads to the C3 convertase C3bBb. The classical and mannose binding lectin activation pathways lead to the C3 convertase C4b2a. These convertases cleave C3 resulting in C3a and C3b. Further degradation leads to formation of the alpha-chain products C3d, C3g and C3c. C3 is an acute phase protein that is produced by a wide range of tissues including renal epithelial cells and hepatocytes.
|Product type||Polyclonal antibodies|
|Formulation||1 ml (100 μg/ml) 0.2 μm filtered protein G purified antibody solution in PBS, containing 0.1% bovine serum albumin and 0.02% sodium azide.|
|Alias||Complement component C3, HSE-MSF Gene name: C3|
|Storage and stability||Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.|
|Precautions||For research use only. Not for use in or on humans or animals or for diagnostics. It is the responsibility of the user to comply with all local/state and Federal rules in the use of this product. Hycult Biotech is not responsible for any patent infringements that might result with the use of or derivation of this product.|
|Disease||Infectious diseases, Nephrology|
Application:F, IF, P, W
Application Notes:F: Sections were permeabilized in cold acetone for 10 minutes. P: Epitope retrieval for the FFPE sections was performed using the PT-module (Lab Vision) with heat induced epitope retrieval pH 9 (HIER).
Positive Control:Kidney, spleen
Use:Dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50.
1. Cashman, S et al; Expression of complement component 3 (C3) from an adenovirus leads to pathology in the murine retina. Inv Opht Vis Scie 2011, 52: 3436 2. Bengtson, A et al; Pharmacokinetics, Tolerability, and Preliminary Efficacy of Paquinimod (ABR-215757), a New Quinoline-3-Carboxamide Derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus. Arthritis Rheum 2012, 64: 1579 3. Tati, R et al. Complement activation associated with ADAMSTS13 deficiency in human and murine thrombotic microangiopathy. JI 2013, 191:2184